Loading...
Loading...
Avricore Health Inc.
Avricore Health Inc.. Spoken Alpha tracks AVCRF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks AVCRF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AVCRF.
curl https://api.spokenalpha.com/v1/companies/AVCRF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.62 | $3.30 | +40.1% | -1.7% | -3.8% |
| Q4 FY2026 | $4.97 | $3.37 | +47.4% | -1.2% | +0.5% |
| Q3 FY2026 | $5.03 | $3.40 | +47.8% | -5.2% | -5.9% |
| Q2 FY2026 | $4.65 | $3.38 | +37.5% | +2.4% | +1.3% |
| Q1 FY2025 | $4.55 | $3.29 | +38.2% | -6.4% | -5.6% |
| Q4 FY2025 | $4.67 | $3.27 | +42.9% | -4.8% | -6.2% |
| Q3 FY2025 | $4.81 | $3.46 | +38.9% | +3.1% | +3.9% |
| Q2 FY2025 | $4.74 | $3.40 | +39.3% | +4.0% | +2.2% |
| Q1 FY2024 | $5.07 | $3.51 | +44.5% | -3.3% | -5.8% |
| Q4 FY2024 | $4.84 | $3.32 | +45.8% | +2.9% | +3.0% |